sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
26 Nov 2009
6,610.00ZAX
6,610.00
26 Nov 2009
-2.07%
6,750.00
6,676.00
325,845
6,743.00
6,600.00
6,825.00
3,103.00
0.42
776,950
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Dlamini, Nobuhle |
Non-Executive Chairman of the Board |
600,000 |
| Saad, Stephen |
Group Chief Executive, Executive Director |
8,500,000 |
| Attridge, Michael |
Deputy Group Chief Executive, Executive Director |
7,100,000 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
24,344.96 |
| Shares Outstanding (Mil.) |
360.67 |
| Float (Mil.) |
337.89 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend ( ZAX) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
0.99 |
| Current Ratio |
1.33 |
| LT Debt/Equity |
91.47 |
| Total Debt/Equity |
158.18 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
18.17 |
| Price/Sales(TTM) |
2.88 |
| Price/Book(TTM) |
6.05 |
| Price/Cash Flow(TTM) |
15.67 |
| |
|
| Per Share Data |
| Earnings(TTM) |
3.72 |
| Sales(TTM) |
23.34 |
| Book Value(MRQ) |
11.60 |
| Cash Flow(TTM) |
4.29 |
| Cash(MRQ) |
5.73 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
37.36 |
| Return on Assets(TTM) |
11.49 |
| Return on Investment(TTM) |
22.16 |
| |
|
| Margins |
| Gross Margin(TTM) % |
45.99 |
| Operating Margin(TTM) % |
25.83 |
| Profit Margin(TTM) % |
15.89 |
|
| |
|